Imatinib Mesylate Attenuates Myocardial Remodeling Through Inhibition of Platelet-Derived Growth Factor and Transforming Growth Factor Activation in a Rat Model of Hypertension
Sung-Won Jang(Catholic University of Korea), Ki‐Bae Seung, Kiyuk Chang(St. Mary's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Okran Kim(Catholic University of Korea), Chanseok Park(Catholic University of Korea), Sang‐Hyun Ihm(The Catholic University of Korea Bucheon St. Mary's Hospital), Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 26
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
|Circulation|2013|281